Incidence of left ventricular thrombi in reperfused STEMI patients detected by contrast-enhanced CMR
Journal of Cardiovascular Magnetic Resonance volume 17, Article number: P164 (2015)
Left ventricular (LV) thrombus formation remains a well-recognized complication following acute ST-segment elevation myocardial infarction (STEMI) in the primary percutaneous coronary intervention (PPCI) era, with potential devastating consequences such as embolic stroke. Echocardiography-based assessment of anterior STEMI patients, within the first 3 months of presentation, has reported an incidence of LV thrombi ranging from 8 to 15%. CMR not only provides higher resolution anatomical images but also has the ability for tissue characterization. Therefore, we hypothesize the true incidence of LV thrombi in reperfused STEMI patients using contrast-enhanced CE-CMR within one week would be more accurate.
139 PPCI-reperfused STEMI patients were recruited from two UK centres between July 2011 and September 2014. CE-CMR was performed at a median of 3 (2-5) days following admission [4 (2-5) days for anterior STEMI patients] on one of the 2 available scanners (1.5T Magnetom Siemens, Avanto and 3T Bio-graph mMR Siemens). Early post contrast images were acquired using a fixed long-inversion recovery time (TI) technique to null avascular tissue (Fig. 1). All cases of identified LV thrombi were diagnosed by an experienced investigator. To distinguish LV thrombi from areas of microvascular obstruction, the following previously described criteria were applied: (1) location (intra-cavity versus intra-myocardial); (2) contrast fill-in on subsequent late gadolinium enhanced images; and (3) differences in appearance (well-defined with sharp borders versus patchy and inhomogeneous) (Fig. 2).
All patients were successfully revascularized by PPCI. The majority of the patients were male (84%), the mean age was 59±11 years old, and the infarct related artery was as follows: LAD (50%), RCA (35%) and Cx (15%). Acute LV thrombi were identified in 19 out of the 139 patients, giving an overall incidence of 14% for all STEMI patients. All the LV thrombi were confined to patients presenting with an acute anterior STEMI (N=69 patients), and all were located at the apex, giving an incidence of 28% in anterior STEMI patients.
CE-CMR at a median of 4 days detects a higher incidence of LV thrombi (28% of anterior STEMI patients) compared to previously reported studies using echocardiography (at a later time point). This is despite the use of anti-thrombotic therapy during PPCI, and subsequent dual anti-platelet therapy.
This work was supported by the British Heart Foundation (FS/10/039/28270;FS/10/72/28568), the Rosetrees Trust, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre.
About this article
Cite this article
Bulluck, H., White, S.K., Yellon, R.L. et al. Incidence of left ventricular thrombi in reperfused STEMI patients detected by contrast-enhanced CMR. J Cardiovasc Magn Reson 17 (Suppl 1), P164 (2015). https://doi.org/10.1186/1532-429X-17-S1-P164